CN Patent

CN110872270A — 一种环己烷衍生物的盐

Assigned to SHANGHAI JINGXIN BIOLOGICAL MEDICAL CO Ltd · Expires 2020-03-10 · 6y expired

What this patent protects

本发明涉及一种如式I所示化合物环己烷衍生物N′‑[反式‑4‑[2‑[7‑(苯并[b]噻吩)‑7‑哌嗪基]乙基]环己基]‑N，N‑二甲基脲的磷酸盐及其晶型。该磷酸盐经体内实验证明其生物利用度高、半衰期较长，是式I化合物的理想盐基。

USPTO Abstract

本发明涉及一种如式I所示化合物环己烷衍生物N′‑[反式‑4‑[2‑[7‑(苯并[b]噻吩)‑7‑哌嗪基]乙基]环己基]‑N，N‑二甲基脲的磷酸盐及其晶型。该磷酸盐经体内实验证明其生物利用度高、半衰期较长，是式I化合物的理想盐基。

Drugs covered by this patent

cariprazine-hydrochloride (CARIPRAZINE HYDROCHLORIDE)

Patent Metadata

Patent number: CN110872270A
Jurisdiction: CN
Classification: —
Expires: 2020-03-10
Drug substance claim: No
Drug product claim: No
Assignee: SHANGHAI JINGXIN BIOLOGICAL MEDICAL CO Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.